463 related articles for article (PubMed ID: 9197269)
1. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Tanda G; Pontieri FE; Di Chiara G
Science; 1997 Jun; 276(5321):2048-50. PubMed ID: 9197269
[TBL] [Abstract][Full Text] [Related]
2. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
Tanda G; Loddo P; Di Chiara G
Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
[TBL] [Abstract][Full Text] [Related]
3. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.
Pistis M; Muntoni AL; Pillolla G; Gessa GL
Eur J Neurosci; 2002 Jun; 15(11):1795-802. PubMed ID: 12081659
[TBL] [Abstract][Full Text] [Related]
5. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
Hoffman AF; Oz M; Caulder T; Lupica CR
J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
[TBL] [Abstract][Full Text] [Related]
6. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH
J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
8. Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats.
Cadoni C; Simola N; Espa E; Fenu S; Di Chiara G
Addict Biol; 2015 Jan; 20(1):132-42. PubMed ID: 23957273
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
Szabo B; Siemes S; Wallmichrath I
Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
[TBL] [Abstract][Full Text] [Related]
10. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse.
Tanda G; Di Chiara G
Eur J Neurosci; 1998 Mar; 10(3):1179-87. PubMed ID: 9753186
[TBL] [Abstract][Full Text] [Related]
11. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
13. Two distinctive antinociceptive systems in rats with pathological pain.
Mao J; Price DD; Lu J; Keniston L; Mayer DJ
Neurosci Lett; 2000 Feb; 280(1):13-6. PubMed ID: 10696800
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
Rinaldi-Carmona M; Barth F; Héaulme M; Alonso R; Shire D; Congy C; Soubrié P; Brelière JC; Le Fur G
Life Sci; 1995; 56(23-24):1941-7. PubMed ID: 7776817
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro M; Carrera MR; Fratta W; Valverde O; Cossu G; Fattore L; Chowen JA; Gomez R; del Arco I; Villanua MA; Maldonado R; Koob GF; Rodriguez de Fonseca F
J Neurosci; 2001 Jul; 21(14):5344-50. PubMed ID: 11438610
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
17. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
[TBL] [Abstract][Full Text] [Related]
18. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
19. Behavioral sensitization to WIN55212.2 in rats pretreated with heroin.
Pontieri FE; Monnazzi P; Scontrini A; Buttarelli FR; Patacchioli FR
Brain Res; 2001 Apr; 898(1):178-80. PubMed ID: 11292463
[TBL] [Abstract][Full Text] [Related]
20. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
